Esketamine nasal spray for depression: Mayo Clinic Radio

Dr. Jennifer Vande Voort, a Mayo Clinic psychiatrist, discusses esketamine nasal spray — a fast-acting treatment for depression that recently was approved by the Food and Drug Administration.

To learn more about depression, visit:

This interview originally aired April 6, 2019.

Products You May Like

Articles You May Like

Like Eating Late? New Study Sheds Light On Why You Should Kick The Habit
Autumn watch: how to help our hibernating animal friends
How to Choose a Medical School
Why Most Americans Don’t Want To Get The Flu Shot This Season
Study Confirms Link Between COVID-19 Vaccination And Increased Menstrual Cycle Length

Leave a Reply

Your email address will not be published.